Algeria's Saidal group signed on Tuesday a partnership agreement with the Jordan-based Arab Company for Drug Industries and Medical Appliances (ACDIMA) to carry out bio-equivalence studies in Algeria, the official Algerian news agency APS reported.
According to the agreement, the two sides will create a joint venture to carry out "compliance studies of generic drugs with the original ones." The joint-venture, in which Saidal will hold a 60-percent ownership and Acdima 40 percent, will be "squarely independent" from Saidal for transparency reasons, the Algerian firm said.
Generic manufacturers in Algeria currently buy their pharmaceutical records in order to use them in the domestic drug production.
ACDIMA is a pan-Arab shareholding company established by a resolution from the Arab Economic Unity Council in 1976. It aims to build relations with multinational bodies to assist in setting up and participating in projects in the Arab World.
Saisal is an Algerian company founded by the government in 1982.
GMT 00:37 2018 Wednesday ,24 January
Bitcoin slumps below $10,000GMT 22:49 2018 Tuesday ,23 January
Sharjah apartment rents see steep decline in 2017GMT 19:15 2018 Tuesday ,23 January
Emirati fined Dh2.2m for embezzling public fundsGMT 22:27 2018 Monday ,22 January
Jafza bridge benefits trade, logistics supply chainGMT 22:21 2018 Monday ,22 January
Damac chairman to speak on digital skillsGMT 10:55 2018 Monday ,22 January
Bahrain-Indian economic ties discussedGMT 22:42 2018 Saturday ,20 January
'Massive' infrastructure spending needed in AfricaGMT 12:49 2018 Tuesday ,16 January
Tabarak Buys Majority Stake in a Private CompanyMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor